Fields
Biology / Medical Market & OrgnaisationSectors
Health
There is a need for new, efficacious anticancer agents associated with increased response rates and with limited and manageable toxicity. The present offer proposes a novel chemical compound with antiproliferative and anti-vascular properties validated in vitro and in vivo. This compound has shown high efficient anti-cancer potency in in vitro models using 24 cancer cell lines (some of them being resistant to chemotherapies). In vivo, this compound has shown a tumor volume reduction of 80-95% on lung and colon murine tumors with no major identified side effects.
Competitive advantages:
Applications:
Keywords:
Cancer, Anti-proliferative, Anti-Vascular, Tumor Therapy, Small molecule